NeOnc Technologies raises $2M in stock and warrant offering for NEO216 preclinical trials

NEONC TECHNOLOGIES HOLDINGS, INC.

Initial closing of 277,777 shares and warrants at $7.20/share for ~$2M from one institutional investor.
Total offering up to 406,694 shares and warrants at $7.20 per share; warrants exercisable at $9.00.
Net proceeds to fund NEO216 preclinical trials.
Fourth securities purchase agreement; offering terminates April 30, 2026.
Shares and warrants issued in unregistered transaction under Section 4(a)(2) of the Securities Act.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.